Dedicated experts. Straightforward pricing. Perfect partnership.
DSP is regarded as the expert CRO in women’s health and reproductive endocrinology/infertility, having conducted 80% of all infertility studies in the United States over the past 18 years.
We’ve been named one of the fastest growing women-owned, women-led businesses in North America, and we continue to focus on what is most important to us: the needs of small to midsize pharmaceutical companies who too often get overcharged and underserviced.
If we sound like the right fit, let’s talk about how we can work together.
DSP takes a proactive, meticulous approach to customer studies and services. We understand customer needs and won’t settle for anything less than precision and accuracy for your clinical trial.
We provide an effortless contracting process with fixed pricing, integrated budgeting and no long-term contracts to simplify service delivery and minimize overhead.
Over the years, we have managed and/or monitored more than 200 Phase I – IV clinical trials in various therapeutic areas, and have filed 26 New Drug Applications (NDA).
Although we take the utmost pride in advancing women’s health and reproductive endocrinology/infertility studies, DSP has also conducted extensive work in the following therapeutic areas:
Pain (Device and Drug)
Central Nervous System
Device (Human and Lab)
Phase I (Healthy and Target Population)
Request a call back.
Would you like to speak to us over the phone? Just submit your details and we’ll be in touch shortly.